GLI1 and neoplasm: Cyclopamine, an inhibitor of the transmembrane protein SMO, has shown efficacy against CML stem cells in vitro and in vivo [141], while GANT61, a GLI, inhibitor, blocks GLI function, inhibiting tumor cell growth (Figure 3).